Level Chart

Basic Info

Becton Dickinson and Co (BDX) - Pharmaceutical Systems Revenue is at a current level of 575.00M, up from 418.00M last quarter and up from 570.00M one year ago. This is a change of 37.56% from last quarter and 0.88% from one year ago.

Region United States
Source Fiscal.ai

Data provided via Fiscal.ai

Stats

Last Value 575.00M
Latest Period Mar 2025
Last Updated Jul 31 2025, 08:47 EDT
Next Release Oct 31 2025, 08:30 EDT (E)
Average Growth Rate 25.43%
Value from Last Quarter 418.00M
Change from Last Quarter 37.56%
Value from 1 Year Ago 570.00M
Change from 1 Year Ago 0.88%
Frequency Quarterly
Unit USD
Adjustment N/A

Historical Data

View and export this data back to 2019. Upgrade now.
Date Value
March 31, 2025 575.00M
December 31, 2024 418.00M
September 30, 2024 677.00M
June 30, 2024 594.00M
March 31, 2024 570.00M
December 31, 2023 431.00M
September 30, 2023 659.00M
June 30, 2023 594.00M
March 31, 2023 567.00M
December 31, 2022 409.00M
September 30, 2022 581.00M
Date Value
June 30, 2022 523.00M
March 31, 2022 501.00M
December 31, 2021 397.00M
September 30, 2021 552.00M
June 30, 2021 476.00M
March 31, 2021 462.00M
December 31, 2020 339.00M
September 30, 2020 485.00M
June 30, 2020 403.00M
March 31, 2020 400.00M
December 31, 2019 299.00M

Basic Info

Becton Dickinson and Co (BDX) - Pharmaceutical Systems Revenue is at a current level of 575.00M, up from 418.00M last quarter and up from 570.00M one year ago. This is a change of 37.56% from last quarter and 0.88% from one year ago.

Region United States
Source Fiscal.ai

Data provided via Fiscal.ai

Stats

Last Value 575.00M
Latest Period Mar 2025
Last Updated Jul 31 2025, 08:47 EDT
Next Release Oct 31 2025, 08:30 EDT (E)
Average Growth Rate 25.43%
Value from Last Quarter 418.00M
Change from Last Quarter 37.56%
Value from 1 Year Ago 570.00M
Change from 1 Year Ago 0.88%
Frequency Quarterly
Unit USD
Adjustment N/A

Related Securities

Symbol Name Change %
BDX Becton, Dickinson & Co. 0.10%